Intellicell Biosciences Inc (fka SVFC)

[hen81]

SVFC...why this pig till at bottom
look at CYTX same tem cell

8:01 am Cytori Therapeutics announces it received approval from FDA to expand the number of Scleroderma clinical trial sites from 12 to 20 centers in the United States (CYTX) : Co announces it received approval from FDA to expand the number of Scleroderma clinical trial sites from 12 to 20 centers in the United States. The STAR study is an 80 patient pivotal clinical trial approved by FDA in January 2015 to study the effects of Cytori's lead drug ECCS-50 for treatment of patients with hand manifestations of Scleroderma.